Basics Zentalis Pharmaceuticals, Inc. IPO Date: April 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $92.1M Activated in VL: True Average Daily Range Avg Daily Range: $0.92 | 3.42% Avg Daily Range (30 D): $0.04 | 2.94% Avg Daily Range (90 D): $0.07 | 4.22% Institutional Daily Volume Avg Daily Volume: .6M Avg Daily Volume (30 D): .71M Avg Daily Volume (90 D): 1.06M Trade Size Avg Trade Size (Sh.): 84 Avg Trade Size (Sh.) (30 D): 171 Avg Trade Size (Sh.) (90 D): 174 Institutional Trades Total Inst.Trades: 1,906 Avg Inst. Trade: $2.1M Avg Inst. Trade (30 D): $1.06M Avg Inst. Trade (90 D): $1.05M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.74M Avg Closing Trade (30 D): $1.06M Avg Closing Trade (90 D): $.95M Avg Closing Volume: 115.69K     News Jun 2, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Apr 1, 2025 @ 9:30 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Mar 15, 2025 @ 3:25 PM Zentalis Pharmaceuticals Presents Updated Clinical... Source: N/A Mar 3, 2025 @ 10:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Feb 3, 2025 @ 10:42 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.67 $-.66 $-2.33 Diluted EPS $-.67 $-.66 $-2.33 Revenue $ M $ 26.87M $ 67.43M Gross Profit $ $ $ Net Income / Loss $ -48.28M $ -47.47M $ -165.87M Operating Income / Loss $ -45.62M $ -49.85M $ -191.19M Cost of Revenue $ $ $ Net Cash Flow $ 8.03M $ -7.42M $ 5.81M PE Ratio